Haoxi Health Tech Files 6-K for FY23 Results

TL;DR

Haoxi Health Tech dropped its 6-K with H2 2023 financials and recent news. Check it out.

AI Summary

Haoxi Health Technology Limited filed a Form 6-K on May 31, 2024, to report its financial results for the six months ended December 31, 2023. The filing also discusses recent corporate developments and includes a press release dated May 31, 2024.

Why It Matters

This filing provides investors with updated financial performance and corporate news for Haoxi Health Technology Limited, crucial for assessing the company's current standing and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial filing (6-K) providing an update on past results and corporate developments, not indicating new significant risks.

Key Players & Entities

• Haoxi Health Technology Limited (company) — Filer of the report
• May 31, 2024 (date) — Date of the press release and filing
• December 31, 2023 (date) — End of the reporting period for financial results

FAQ

Filing Documents

• ea0206816-6k_haoxi.htm (6-K) — 15KB
• ea020681601ex99-1_haoxi.htm (EX-99.1) — 74KB
• 0001213900-24-048183.txt ( ) — 90KB

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS in this current report with respect to the Company’s current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of the Company. Forward-looking statements include, but are not limited to, those statements using words such as “believe,” “expect,” “plan,” “strategy,” “prospects,” “forecast,” “estimate,” “project,” “anticipate,” “aim,” “intend,” “seek,” “may,” “might,” “could” or “should,” and words of similar meaning in connection with a discussion of future operations, financial performance, events or conditions. From time to time, oral or written forward-looking statements may also be included in other materials released to the public. These statements are based on management’s assumptions, judgments and beliefs in light of the information currently available to it. The Company cautions investors that a number of important risks and uncertainties could cause actual results to differ materially from those discussed in the forward-looking of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission. Therefore, investors should not place undue reliance on such forward-looking statements. Actual results may differ significantly from those set forth in the forward-looking statements. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this current report on Form 6-K to be signed on its behalf by the undersigned, thereunto duly authorized. Haoxi Health Technology Limited Date: May 31, 2024 By: /s/ Zhen Fan Name: Zhen Fan Title: Chief Executive Officer 3

View Full Filing

View this 6-K filing on SEC EDGAR